Connection

Júlia Vergara-Alert to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Júlia Vergara-Alert has written about Antibodies, Viral.
Júlia Vergara-Alert
Connection Strength
0.074
Antibodies, Viral
  1. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
    View in: PubMed
    Score: 0.022
  2. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein. Emerg Microbes Infect. 2019; 8(1):1593-1603.
    View in: PubMed
    Score: 0.019
  3. Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model. PLoS One. 2012; 7(7):e40524.
    View in: PubMed
    Score: 0.012
  4. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. Emerg Microbes Infect. 2021 Dec; 10(1):797-809.
    View in: PubMed
    Score: 0.006
  5. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals. Viruses. 2021 06 12; 13(6).
    View in: PubMed
    Score: 0.006
  6. Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins. Immunotherapy. 2020 12; 12(17):1247-1255.
    View in: PubMed
    Score: 0.005
  7. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. J Virol. 2015 Nov; 89(22):11654-67.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.